International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
OpenAlex
Works that cite this article, indexed by OpenAlex.
Personalized medicine in breast cancer: pharmacogenomics approaches
Pharmacogenomics and Personalized Medicine Volume 12 (2019)
Shabnam Jeibouei; Mohammad Esmael Akbari; Alireza Kalbasi; Amir Reza Aref; Mohammad Ajoudanian; Alireza Rezvani; Hakimeh Zali
Omics Technologies Improving Breast Cancer Research and Diagnostics
International Journal of Molecular Sciences 24(16) (2023)
Arianna Orsini; Chiara Diquigiovanni; Elena Bonora
The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trials
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1872(2) (2019)
Omar Najim; Sofie Seghers; Laurine Sergoynne; Hélène Van Gaver; Konstantinos Papadimitriou; Kristien Wouters; Xuan Bich Trinh; Manon Thirza Huizing; Wiebren A.A. Tjalma
Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds
Journal of Neuroendocrinology 32(1) (2019)
Oscar Hidalgo‐Lanussa; Eliana Báez-Jurado; Valentina Echeverrı́a; Ghulam Md Ashraf; Amirhossein Sahebkar; Luis Miguel García‐Segura; Roberto Cosimo Melcangi; George Emilio Barreto
Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer
International Journal of Molecular Sciences 21(22) (2020)
Nuri Lee; Min-Jeong Park; Wonkeun Song; Kibum Jeon; Seri Jeong
Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis
Frontiers in Oncology 13 (2023)
Omar Najim; Konstantinos Papadimitriou; Glenn Broeckx; Manon Thirza Huizing; Wiebren A.A. Tjalma
Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells
Cancer Biology & Therapy 19(8) (2018)
Ling Cheng; Ying Tang; Xing Chen; Lei Zhao; Songya Liu; Yanna Ma; Na Wang; Kuangguo Zhou; Jianfeng Zhou; Mi Zhou
The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1)
Cancer Treatment and Research Communications 19 (2019)
Omar Najim; Manon Thirza Huizing; Konstantinos Papadimitriou; Xuan Bich Trinh; Patrick Pauwels; Sofie Goethals; Karen Zwaenepoel; Kevin Peterson; Joost Weyler; Sevilay Altıntaş; Peter A. van Dam; Wiebren A.A. Tjalma
Importance of genetic background of oxysterol signaling in cancer
Biochimie 153 (2018)
Petr Holý; A. Kloudova; Pavel Souček
Association between interleukin‐1 receptor antagonist (IL‐1ra) VNTR, gene polymorphism and breast cancer susceptibility in Iranian population: Experimental and web‐based analysis
International Journal of Immunogenetics 49(4) (2022)
Reza Ibrahimi; Mostafa Ibrahimi; Behzad Jamalzei; Mohammad Esmaeil Akbari; Mohsen Navari; Maryam Moossavi; Milad Khorasani
Long non-coding RNA GHET1 Is Possibly Involved in the Pathogenesis of a Fraction of Breast Cancers
International Journal of Cancer Management 10(10) (2017)
Shaghayegh Sarrafzadeh; Mohammad Naser Taheri; Lobat Geranpayeh; Somayyeh Ghafouri-Fard; Soudeh Ghafouri‐Fard; Soudeh Ghafouri‐Fard; Soudeh Ghafouri‐Fard
Genomics Role in Cancer Immunosurveillance: Impact on Immunotherapy Response
International Journal of Cancer Management In Press(In Press) (2018)
Sanaz Tabarestani; Mohammad Esmaeil Akbari; Saeed Namaki
Novel Approaches to Immunotherapy in Triple Negative Breast Cancer
International Journal of Cancer Management In Press(In Press) (2018)
Sanaz Tabarestani; Mohammad Esmaeil Akbari; Saeed Namaki